Thomas Kolaras
Chief Commercial Officer (CCO) US, SERB Pharmaceuticals
Professional Overview
Thomas Kolaras is an accomplished pharmaceutical executive with over a decade of experience driving commercial strategy and leading high-performance teams. As the Chief Commercial Officer (CCO) for the US at SERB Pharmaceuticals, he is responsible for overseeing all commercial activities, including sales, marketing, and market access, to expand the company's presence and drive revenue growth.
Experience Summary
Current Role
As the CCO of SERB Pharmaceuticals' US operations, Thomas is responsible for developing and executing the company's commercial strategy to support the launch and growth of its specialty pharmaceutical products. He leads a team of over 200 sales and marketing professionals, and under his leadership, the US business has achieved significant market share gains and revenue growth.
Career Progression
Prior to his current role, Thomas held several senior leadership positions at Endo Pharmaceuticals, including Senior Vice President of US Specialty Marketing, Vice President of Marketing Specialty & Established Products, and Vice President & General Manager of the Pain Business Unit. He also served as the Founder and President of SteelCut Marketing, a boutique healthcare consulting firm, and held a senior role in the CNS Patient and Branding Strategy team at Otsuka America Pharmaceutical, Inc.
Throughout his career, Thomas has demonstrated a strong track record of driving business growth, launching new products, and building high-performing teams. His deep understanding of the pharmaceutical industry, coupled with his expertise in commercial operations, has positioned him as a respected leader within the sector.
Academic Background
Thomas holds a Bachelor's degree in Business Administration from the University of Pennsylvania's Wharton School of Business, where he graduated with honors.
Areas of Expertise
- Pharmaceutical commercial strategy and operations
- New product launch and commercialization
- Sales force management and optimization
- Marketing and brand strategy development
- Market access and payer relations
- Business development and strategic partnerships
Professional Impact
Under Thomas's leadership, SERB Pharmaceuticals' US business has achieved significant growth, with the company's flagship product becoming a market leader in its therapeutic category. He has also been actively involved in industry associations, sharing his expertise and contributing to the development of best practices in pharmaceutical commercial operations.
Conclusion
With his extensive experience, strategic vision, and proven track record of success, Thomas Kolaras is a valuable asset to SERB Pharmaceuticals. As the CCO, he is well-positioned to continue driving the company's commercial growth and solidifying its position as a leading player in the US pharmaceutical market.
